Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.40
Delayed Data
As of Jan 19
 -0.01 / -0.12%
Today’s Change
5.49
Today|||52-Week Range
9.88
-1.98%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close8.41
Today’s open8.39
Day’s range8.33 - 8.49
Volume181,927
Average volume (3 months)302,115
Market cap$660.3M
Dividend yield--
Data as of 01/19/2017

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+130.00%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book3.04

Competitors

 Today’s
change
Today’s
% change
FMIFoundation Medicine ...-0.05-0.27%
NTRANatera Inc-0.11-1.12%
GHDXGenomic Health Inc-0.76-2.72%
NVTAInvitae Corp-0.39-4.68%
Data as of 01/19/2017

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts


Search for Jobs